[1]杜晨蕾,吴 静,赵 琨,等.公共卫生监测系统卫生经济学评价的研究[J].卫生经济研究,2018,(11):23-26.
　DU Chen-lei,WU Jing,ZHAO Kun,et al.Research on Health Economic Evaluation of Public Health Monitoring System[J].Journal Press of Health Economics Research,2018,(11):23-26.
点击复制

公共卫生监测系统卫生经济学评价的研究

卫生经济研究[ISSN:1004-7778/CN:33-1056/F]

卷:
期数:
2018年11期
页码:
23-26
栏目:
经济学评价
出版日期:
2018-10-29

文章信息/Info

Title:
Research on Health Economic Evaluation of Public Health Monitoring System
作者:
杜晨蕾1; 吴 静1; 赵 琨2; 郭武栋2; 王嘉艺3
1.中国疾病预防控制中心慢性非传染性疾病预防控制中心，北京 1000508
2.国家卫生计生委卫生发展研究中心，北京 1000838
3.内蒙古医科大学，内蒙古 呼和浩特 0101108
Author(s):
DU Chen-lei; WU Jing; ZHAO Kun; GUO Wu-dong; WANG Jia-yi
Chinese Center for Disease Control and Prevention，Chronic Non-communicable Disease Prevention and Control Center，Beijing 100050，China
关键词:
公共卫生监测; 卫生经济学评价
Keywords:
public health monitoring; health economic evaluation
分类号:
R19
文献标志码:
A
摘要:
卫生经济学评价支持公共卫生决策。本文梳理公共卫生监测系统的卫生经济学评价研究现状，在借鉴国内外相关研究的基础上，对我国公共卫生监测系统的卫生经济学评价提出建议。
Abstract:
Health economics evaluation supports public health decision-making. This paper provided the research status of health economic evaluation of public health monitoring system，and made recommendations on the health economic evaluation of public health monitoring system in China based on relevant research at home and abroad.

参考文献/References:

[1] 胡红濮, 代涛, 高星. 加拿大卫生决策支持系统的发展与启示[Z].中国医学科学院/北京协和医学院医学信息研究所/图书馆2011年学术年会， 2012.
[2] 石菊芳, 代敏. 中国癌症筛查的卫生经济学评价[J]. 中华预防医学杂志, 2017, 51(2).
[3] 刘万洋, 刘炯, 陈杰,等. 发展中国家公共卫生监测[J]. 中国卫生事业管理, 2003, 19(12):763-764.
[4] World Health Organization. Protocol for the evaluation of epidemiological surveillance systems[M]. Geneva: WHO, 1997
[5] Centers for Disease Control. Guidelines for evaluating surveillance systems[J]. MMWR Rep, 1988, 37(Suppl 5): S1-18.
[6] Health Surveillance Coordinating Committee. Framework and tools for evaluating health surveillance systems[M]. Vancouver: Health Canada, 2004.
[7] European Centre for Disease Prevention and Control. Framework for the evaluation and assessment of EU-wide surveillance networks in 2006-2008[EB/OL].（2006-08-21）[2018-04-16]. https://ecdc. europa. eu / en / publications-data / frameworkevaluation-and-assessment-eu-wide-surveillance-networks-2006- 2008.
[8] Calba C, Goutard F L, Hoinville L, et al. Surveillance systems evaluation: a systematic review of the existing approaches[J]. Bmc Public Health, 2015, 15(1):1-13.
[9] Auer A M, Dobmeier T M, Bo J H, et al. The relevance of WHO injury surveillance guidelines for evaluation: learning from the aboriginal community-centered injury surveillance system (ACCISS) and two institution-based systems[J]. Bmc Public Health, 2011, 11(1):744.
[10] Buehler JW, Hopkins RS, Overhage JM, et al. Framework for evaluating public health surveillance systems for early detection of outbreaks: Recommendations of a CDC Working Group[J]. MMWR Recomm Rep, 2004, 53（RR5）：1-11.
[11] 王剑, 赵加奎, 魏晓敏,等. 经济学评价方法现状及在公共卫生领域的应用[J]. 中国卫生资源, 2013(5):353-355.
[12] 肖军, 孙谨芳, 王琦琦,等. 卫生经济学评价报告指南及应用现状[J]. 中华预防医学杂志, 2017, 51(3).
[13] WHO. WHO Guide to cost-effectiveness analysis[EB/OL]. http://apps.who.int/iris/bitstream/handle/10665/42699/9241546018.pdf?sequence=1.
[14] Anker M. Evaluating the costs and benefits of national surveillance and response systems. Methodologies and options[R]. WHO, 2005.
[15] 蔡智强, 李丽萍, 白雲屏. 公共卫生监测的过去、现在和未来[J]. 疾病监测, 2015, 30(10):810-817.
[16] 陈向阳, 秦侠. 2012—2015年温州市麻风病可疑症状监测系统卫生经济学评价[J]. 现代预防医学, 2016, 43(17):3154-3156.
[17] 沈云良, 严丽英, 孔文明,等. 浙江省麻风可疑症状监测系统卫生经济学评价[J]. 中国麻风皮肤病杂志, 2014(12):707-709.
[18] Guo X, Claassen G D, Oude Lansink A G, et al. Economic Analysis of Classical Swine Fever Surveillance in the Netherlands[J]. Transboundary & Emerging Diseases, 2016, 63(3):296-313.
[19] 张红强, 王艳芳, 李六九. 玉溪市疾病监测信息系统运行效果及成本分析[J]. 职业与健康, 2007, 23(21):1952-1954.
[20] Ding Y, Sauerborn R, Xu B, et al. A cost-effectiveness analysis of three components of a syndromic surveillance system for the early warning of epidemics in rural China[J]. Bmc Public Health, 2015, 15(1):1-9.
[21] Hadorn D C, Racloz V, Schwermer H, et al. Establishing a cost-effective national surveillance system for Bluetongue using scenario tree modelling[J]. Veterinary Research, 2009, 40(6):57.
[22] Rivière J, Le S Y, Hendrikx P, et al. Cost-effectiveness evaluation of bovine tuberculosis surveillance in wildlife in France (Sylvatub system) using scenario trees.[J]. Plos One, 2017, 12(8):e0183126.
[23] Healy J M, Reisen W K, Kramer V L, et al. Comparison of the Efficiency and Cost of West Nile Virus Surveillance Methods in California[J]. Vector Borne Zoonotic Dis, 2015, 15(2):147-155.
[24] 马悦善, 马新源, 李其龙,等. 恶性肿瘤登记报告的成本分析[J]. 中国肿瘤, 2001, 10(7):384-385.
[25] Joshi R, Praveen D, Jan S, et al. How much does a verbal autopsy based mortality surveillance system cost in rural India?[J]. Plos One, 2015, 10(5):e0126410.
[26] Zanetti R, Sacchetto L, Calvia M, et al. Economic evaluation of cancer registration in Europe[J]. Journal of Registry Management, 2014, 41(1):31-37.
[27] Subramanian S, Tangka F, Edwards P, et al. Developing and testing a cost data collection instrument for noncommunicable disease registry planning[J]. Cancer Epidemiology, 2016, 45.
[28] Wabinga H, Subramanian S, Nambooze S, et al. Uganda experience-Using cost assessment of an established registry to project resources required to expand cancer registration[J]. Cancer Epidemiology, 2016, 45 (Suppl 1):S30.
[29] Koyande S, Subramanian S, Edwards P, et al. Economic evaluation of Mumbai and its satellite cancer registries: Implications for expansion of data collection [J]. Cancer Epidemiology, 2016, 45.
[30] Korir A, Gakunga R, Subramanian S, et al. Economic analysis of the Nairobi Cancer Registry: Implications for expanding and enhancing cancer registration in Kenya[J]. Cancer Epidemiology, 2016, 45 (Suppl 1):S20.
[31] Tangka F K, Subramanian S, Edwards P, et al. Resource requirements for cancer registration in areas with limited resources: Analysis of cost data from four low- and middle-income countries[J]. Cancer Epidemiology, 2016, 45 (Suppl 1):S50.
[32] Martelly T N, Rose A M, Subramanian S, et al. Economic assessment of integrated cancer and cardiovascular registries: The Barbados experience.[J]. Cancer Epidemiology, 2016, 45.
[33] Vries E D, Pardo C, Arias N, et al. Estimating the cost of operating cancer registries: Experience in Colombia[J]. Cancer Epidemiology, 2016, 45.
[34] 孙利华, 宗欣. 对我国药物经济学评价中贴现率选择问题的思考[J]. 中国新药杂志, 2010(9):737-739.

相似文献/References:

[1]王 沛.我国医学营养治疗经济学评价的系统性综述[J].卫生经济研究,2020,(07):16.
　WANG Pei.Systematic Review of the Economic Evaluation of Medical Nutrition Therapy in China[J].Journal Press of Health Economics Research,2020,(11):16.
[2]戴涛明,袁 洁,马月阳,等.老年长期照护经济学评价的进展与政策启示[J].卫生经济研究,2026,43(02):32.
　DAI Taoming,YUAN Jie,MA Yueyang,et al.Progress and Policy Implications of Economic Evaluations of Elderly Long-Term Care[J].Journal Press of Health Economics Research,2026,43(11):32.

更新日期/Last Update: 2018-10-29